Since chronic inflammation has been proposed to generate an environment advantageous to cancer survival, as well as promoting tumourogenesis (NSCLC reviewed in O'Callaghan et al., 2010) the identification of CRP as a risk factor may be due to chronic inflammation. The gene discussed is CRP; the disease is non-small cell lung carcinoma.